Uphando lubonisa ukuba amajoni omzimba e-COVID-19 anokuthintela ukosuleleka kwakhona kwixa elizayo

Kukho ubungqina obutsha bokuba i-antibody ye-COVID-19 yosulelo lwangaphambili iyawunciphisa kakhulu umngcipheko wokosuleleka kwakhona kwixesha elizayo.
Uphononongo olupapashwe ngoLwesithathu kwijenali ye-JAMA Internal Medicine yafumanisa ukuba abantu abavavanywe ukuba banayo i-COVID-19 banomngcipheko oncitshisiweyo wosulelo lwe-coronavirus xa kuthelekiswa nabo bavavanya bangenayo i-antibodies.
UGqr. Douglas Lowy wathi: “Iziphumo zolu hlolisiso ngokusisiseko zincitshiswe ngomlinganiselo we-10, kodwa ndinezimvo ezithile malunga noku.Ngamanye amazwi, oku kunokuba yi-overestimation yokunciphisa.Oku kunokuba yinyani.Ukujongelwa phantsi kokuncipha. ”ngumbhali wesifundo kunye nosekela mlawuli oyintloko weZiko loMhlaza leSizwe.
Uthe: "Kum, owona myalezo mkhulu uncitshisiwe.""Eyona nto ithathwayo kukuba amajoni omzimba emva kosulelo lwendalo ngokuyinxenye anxulumene nokuthintela usulelo olutsha."
U-Lowy wongeze ukuba abantu abapholileyo kwi-COVID-19 kusafuneka bagonywe xa ilithuba labo.
Abaphandi abavela kwiZiko leSizwe loMhlaza kunye neenkampani ezifana neLabCorp, Quest Diagnostics, Aetion Inc. kunye neHealthVerity bafunde idatha yabantu abangaphezu kwezigidi ezi-3.2 eUnited States abagqibe uvavanyo lwe-COVID-19 phakathi kukaJanuwari no-Agasti kulo nyaka uphelileyo.Kolu vavanyo, i-11.6% ye-COVID-19 antibodies yayinayo kwaye i-88.3% yayingenayo.
Kwidatha yokulandela, abaphandi bafumanise ukuba emva kweentsuku ezingama-90, yi-0.3% kuphela yabantu abaye bavavanywa ukuba banayo i-COVID-19 antibodies ekugqibeleni bavavanya ukuba banalo usulelo lwe-coronavirus.Phakathi kwezigulana ezineziphumo zovavanyo lwe-COVID-19, i-3% kamva yafunyaniswa ukuba inosulelo lwe-coronavirus kwangelo xesha linye.
Lilonke, olu phononongo lujongiwe, kwaye lubonisa unxulumano phakathi kwesiphumo sovavanyo lwe-COVID-19 kunye nomngcipheko oncitshisiweyo wokosuleleka emva kweentsuku ezingama-90-kodwa uphando olongezelelweyo luyafuneka ukumisela unobangela kunye nokuba i-antibody ikhuselwe ixesha elingakanani Okokugqibela.
URoy uthe uphando olongezelelweyo luyafuneka ukumisela umngcipheko wokosuleleka kwakhona okubangelwa yenye yeendlela ezisakhulayo ze-coronavirus.
ULowe uthe: “Ngoku kukho ezi zinto zixhalabisayo.Zithetha ukuthini?Eyona mpendulo imfutshane kukuba asazi.”Ukwagxininise ukuba abantu abavavanya ukuba bane-antibodies kufuneka bagonyelwe i-COVID-19.
Kuyaziwa ukuba uninzi lwabaguli abachachayo kwi-COVID-19 bane-antibodies, kwaye ukuza kuthi ga ngoku, ukuphinda kuphinde kuvele kwakhona kubonakala kunqabile-kodwa "kuya kuhlala ixesha elingakanani ukhuseleko lwe-antibody ngenxa yosulelo lwendalo" akukacaci," uGqr Mitchell Katz we-NYC Health + Inkqubo yokhathalelo lwempilo yeSibhedlele yabhala kuhlelo olwapapashwa kunye nophando olutsha kwi-JAMA Internal Medicine.
UKatz ubhale wathi: "Ke ngoko, nokuba sithini na imeko ye-antibody, kuyacetyiswa ukuba ufumane isitofu sokugonya i-SARS-CoV-2."I-SARS-CoV-2 ligama le-coronavirus ebangela i-COVID-19.
Ubhale wathi: “Ubude bexesha lokhuseleko lwe-antibody olunikezelwa ngamayeza okugonya alaziwa.”“Kuyimfuneko ukwazi ukuba luhlala ixesha elingakanani ukhuseleko lwezilwa-buhlungu ngenxa yosulelo lwendalo okanye ugonyo.Lixesha kuphela eliya kuthetha.”
I-Hearst Television ithatha inxaxheba kwiinkqubo ezahlukeneyo zokuthengisa ezihambelanayo, oku kuthetha ukuba sinokufumana iikhomishini ezihlawulelwayo zokuthenga ngeekhonkco kwiiwebhusayithi zabathengisi.


Ixesha lokuposa: Feb-25-2021